Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.

Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen BJ, Sanderman R, Schultz K, Kocks JWH, Van der Molen T.

Health Qual Life Outcomes. 2018 Jun 26;16(1):130. doi: 10.1186/s12955-018-0950-7.

2.

The feasibility of an allergy management support system (AMSS) for IgE-mediated allergy in primary care.

Flokstra-de Blok BMJ, Brakel TM, Wubs M, Skidmore B, Kocks JWH, Oude Elberink JNG, Schuttelaar MA, van der Velde JL, van der Molen T, Dubois AEJ.

Clin Transl Allergy. 2018 May 29;8:18. doi: 10.1186/s13601-018-0206-y. eCollection 2018.

3.

Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.

Kirenga BJ, de Jong C, Mugenyi L, Katagira W, Muhofa A, Kamya MR, Boezen HM, van der Molen T.

Thorax. 2018 May 11. pii: thoraxjnl-2017-211157. doi: 10.1136/thoraxjnl-2017-211157. [Epub ahead of print]

PMID:
29752346
4.

Fostering the exchange of real world data across different countries to answer primary care research questions: an UNLOCK study from the IPCRG.

Cragg L, Williams S, van der Molen T, Thomas M, Correia de Sousa J, Chavannes NH.

NPJ Prim Care Respir Med. 2018 Mar 8;28(1):8. doi: 10.1038/s41533-018-0075-9.

5.

Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.

Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan.

PMID:
29371382
6.

The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa.

van Gemert FA, Kirenga BJ, Gebremariam TH, Nyale G, de Jong C, van der Molen T.

Expert Rev Respir Med. 2018 Mar;12(3):227-237. doi: 10.1080/17476348.2018.1423964. Epub 2018 Jan 10.

PMID:
29298106
7.

Identifying Patient Attitudinal Clusters Associated with Asthma Control: The European REALISE Survey.

van der Molen T, Fletcher M, Price D.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):962-971. doi: 10.1016/j.jaip.2017.10.007. Epub 2017 Nov 20.

8.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003.

PMID:
29169740
9.

Assessment of Burden of COPD tool: evidence not perception.

Slok AHM, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MPMH, Kerstjens HAM, van der Molen T, Asijee GM, Dekhuijzen PNR, Holverda S, Salomé PL, Goossens LMA, Twellaar M, In 't Veen JCCM, van Schayck OCP.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700756. doi: 10.1183/13993003.00756-2017. Print 2017 Jul. No abstract available.

PMID:
28751417
10.

Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review.

Klijn SL, Hiligsmann M, Evers SMAA, Román-Rodríguez M, van der Molen T, van Boven JFM.

NPJ Prim Care Respir Med. 2017 Apr 13;27(1):24. doi: 10.1038/s41533-017-0022-1. Review.

11.

Development of an allergy management support system in primary care.

Flokstra-de Blok BM, van der Molen T, Christoffers WA, Kocks JW, Oei RL, Oude Elberink JN, Roerdink EM, Schuttelaar ML, van der Velde JL, Brakel TM, Dubois AE.

J Asthma Allergy. 2017 Mar 15;10:57-65. doi: 10.2147/JAA.S123260. eCollection 2017.

12.

Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study.

Kocks JWH, Blom CMG, Kasteleyn MJ, Oosterom W, Kollen BJ, Van der Molen T, Chavannes NH.

NPJ Prim Care Respir Med. 2017 Mar 28;27(1):20. doi: 10.1038/s41533-017-0023-0.

13.

Personalising care of adults with asthma from Asia: a modified e-Delphi consensus study to inform management tailored to attitude and control profiles.

Chisholm A, Price DB, Pinnock H, Tan TL, Roa C, Cho SH, David-Wang A, Wong G, van der Molen T, Ryan D, Castillo-Carandang N, Yong YV.

NPJ Prim Care Respir Med. 2017 Mar 23;27:17002. doi: 10.1038/npjpcrm.2017.2. No abstract available.

14.

Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?

van der Molen T, Kocks JW, Tsiligianni IG.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):708-710. doi: 10.1164/rccm.201610-2146ED. No abstract available.

PMID:
28294653
15.

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9.

PMID:
28286157
16.

Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.

Bathoorn E, Groenhof F, Hendrix R, van der Molen T, Sinha B, Kerstjens HA, Friedrich AW, Kocks JW.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 13;12:285-290. doi: 10.2147/COPD.S120510. eCollection 2017.

17.

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial.

Demeyer H, Louvaris Z, Frei A, Rabinovich RA, de Jong C, Gimeno-Santos E, Loeckx M, Buttery SC, Rubio N, Van der Molen T, Hopkinson NS, Vogiatzis I, Puhan MA, Garcia-Aymerich J, Polkey MI, Troosters T; Mr Papp PROactive study group and the PROactive consortium.

Thorax. 2017 May;72(5):415-423. doi: 10.1136/thoraxjnl-2016-209026. Epub 2017 Jan 30.

18.

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.

Postma DS, Dekhuijzen R, van der Molen T, Martin RJ, van Aalderen W, Roche N, Guilbert TW, Israel E, van Eickels D, Khalid JM, Herings RM, Overbeek JA, Miglio C, Thomas V, Hutton C, Hillyer EV, Price DB.

Allergy Asthma Immunol Res. 2017 Mar;9(2):116-125. doi: 10.4168/aair.2017.9.2.116.

19.

Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria.

Kamusheva M, Dimitrova M, van Boven JF, Postma MJ, van der Molen T, Kocks JW, Mitov K, Doneva M, Petrova D, Georgiev O, Petkova V, Petrova G.

J Med Econ. 2017 May;20(5):503-509. doi: 10.1080/13696998.2017.1279620. Epub 2017 Jan 23.

PMID:
28058859
20.

Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles.

Chisholm A, Price DB, Pinnock H, Lee TT, Roa C, Cho SH, David-Wang A, Wong G, van der Molen T, Ryan D, Castillo-Carandang N, Yong YV.

NPJ Prim Care Respir Med. 2017 Jan 5;27:16089. doi: 10.1038/npjpcrm.2016.89.

21.

[Effectiveness of the Assessment of Burden of COPD tool: a cluster-randomised controlled trial].

van Schayck OC, Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC.

Ned Tijdschr Geneeskd. 2016;160(0):D955. Dutch.

PMID:
27805538
22.

Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist.

van der Molen T, van Boven JF, Maguire T, Goyal P, Altman P.

Br J Clin Pharmacol. 2017 Jan;83(1):192-201. doi: 10.1111/bcp.13087. Epub 2016 Nov 2. Review.

23.

Use of the Control of Allergic Rhinitis and Asthma Test (CARATkids) in children and adolescents: Validation in Dutch.

Emons JA, Flokstra BM, de Jong C, van der Molen T, Brand HK, Arends NJ, Amaral R, Fonseca JA, Gerth van Wijk R.

Pediatr Allergy Immunol. 2017 Mar;28(2):185-190. doi: 10.1111/pai.12678. Epub 2016 Dec 23.

PMID:
27801950
24.

Development of a diagnostic decision tree for obstructive pulmonary diseases based on real-life data.

Metting EI, In 't Veen JC, Dekhuijzen PN, van Heijst E, Kocks JW, Muilwijk-Kroes JB, Chavannes NH, van der Molen T.

ERJ Open Res. 2016 Jan 22;2(1). pii: 00077-2015. eCollection 2016 Jan.

25.

Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG.

Cragg L, Williams S, van der Molen T, Thomas M, Correia de Sousa J, Chavannes NH.

NPJ Prim Care Respir Med. 2016 Sep 22;26:16048. doi: 10.1038/npjpcrm.2016.48. No abstract available.

26.

Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda.

van Gemert F, Chavannes N, Kirenga B, Jones R, Williams S, Tsiligianni I, Vonk J, Kocks J, de Jong C, van der Molen T.

NPJ Prim Care Respir Med. 2016 Sep 1;26:16050. doi: 10.1038/npjpcrm.2016.50.

27.

Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference.

Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Flokstra-de Blok B, Kocks J, Schultz K, van der Molen T.

NPJ Prim Care Respir Med. 2016 Sep 1;26:16041. doi: 10.1038/npjpcrm.2016.41.

28.

"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence.

Braido F, Chrystyn H, Baiardini I, Bosnic-Anticevich S, van der Molen T, Dandurand RJ, Chisholm A, Carter V, Price D; Respiratory Effectiveness Group.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):823-32. doi: 10.1016/j.jaip.2016.03.002. Review.

29.

Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.

van der Molen T, Postma DS, Martin RJ, Herings RM, Overbeek JA, Thomas V, Miglio C, Dekhuijzen R, Roche N, Guilbert T, Israel E, van Aalderen W, Hillyer EV, van Rysewyk S, Price DB.

BMC Pulm Med. 2016 Jul 23;16(1):105. doi: 10.1186/s12890-016-0270-9. No abstract available.

30.

Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.

Tsiligianni I, Metting E, van der Molen T, Chavannes N, Kocks J.

NPJ Prim Care Respir Med. 2016 Jul 21;26:16040. doi: 10.1038/npjpcrm.2016.40.

31.

Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma.

Nieuwenhuis MA, Siedlinski M, van den Berge M, Granell R, Li X, Niens M, van der Vlies P, Altmüller J, Nürnberg P, Kerkhof M, van Schayck OC, Riemersma RA, van der Molen T, de Monchy JG, Bossé Y, Sandford A, Bruijnzeel-Koomen CA, Gerth van Wijk R, Ten Hacken NH, Timens W, Boezen HM, Henderson J, Kabesch M, Vonk JM, Postma DS, Koppelman GH.

Allergy. 2016 Dec;71(12):1712-1720. doi: 10.1111/all.12990. Epub 2016 Aug 22.

32.

[French data from the Continuing to Confront COPD (C2C) survey].

Roche N, Ajjouri R, Compagnon A, Van Der Molen T, Mullerova H.

Rev Mal Respir. 2017 Mar;34(3):180-187. doi: 10.1016/j.rmr.2016.05.001. Epub 2016 Aug 8. French.

PMID:
27423810
33.

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.

Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC, van Schayck OC.

BMJ Open. 2016 Jul 11;6(7):e011519. doi: 10.1136/bmjopen-2016-011519.

34.

[Asthma/COPD service in general practice. Study into feasibility and effectiveness].

Metting EI, Riemersma RA, Kocks JW, Piersma-Wichers MG, Sanderman R, van der Molen T.

Ned Tijdschr Geneeskd. 2016;160(0):D281. Dutch.

PMID:
27378264
35.

Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.

Tsiligianni IG, Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Schultz K, Kollen BJ, van der Molen T, Kocks JW.

Int J Chron Obstruct Pulmon Dis. 2016 May 18;11:1045-52. doi: 10.2147/COPD.S99793. eCollection 2016.

36.

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 27;11:881-90. doi: 10.2147/COPD.S102280. eCollection 2016. Erratum in: Int J Chron Obstruct Pulmon Dis. 2017 Mar 15;12 :859.

37.

Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.

van der Molen T, Postma DS, Martin RJ, Herings RM, Overbeek JA, Thomas V, Miglio C, Dekhuijzen R, Roche N, Guilbert T, Israel E, van Aalderen W, Hillyer EV, van Rysewyk S, Price DB.

BMC Pulm Med. 2016 May 17;16(1):80. doi: 10.1186/s12890-016-0234-0. Erratum in: BMC Pulm Med. 2016;16(1):105.

38.

Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.

Foo J, Landis SH, Maskell J, Oh YM, van der Molen T, Han MK, Mannino DM, Ichinose M, Punekar Y.

PLoS One. 2016 Apr 19;11(4):e0152618. doi: 10.1371/journal.pone.0152618. eCollection 2016.

39.

Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.

Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG.

NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.

40.

The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).

Miravitlles M, Worth H, Soler-Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A.

COPD. 2016 Oct;13(5):561-8. doi: 10.3109/15412555.2016.1150447. Epub 2016 Mar 16.

PMID:
26983349
41.

Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.

Demeyer H, Gimeno-Santos E, Rabinovich RA, Hornikx M, Louvaris Z, de Boer WI, Karlsson N, de Jong C, Van der Molen T, Vogiatzis I, Janssens W, Garcia-Aymerich J, Troosters T, Polkey MI; PROactive consortium.

PLoS One. 2016 Mar 14;11(3):e0151255. doi: 10.1371/journal.pone.0151255. eCollection 2016.

42.

Guidance on the diagnosis and management of asthma among adults in resource limited settings.

Kirenga BJ, Schwartz JI, de Jong C, van der Molen T, Okot-Nwang M.

Afr Health Sci. 2015 Dec;15(4):1189-99. doi: 10.4314/ahs.v15i4.18.

43.

Patient satisfaction with a teleradiology service in general practice.

Jacobs JJWM, Ekkelboom R, Jacobs JPAM, van der Molen T, Sanderman R.

BMC Fam Pract. 2016 Feb 10;17:17. doi: 10.1186/s12875-016-0418-y.

44.

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.

45.

The Assessment of Burden of COPD (ABC) Scale: A Reliable and Valid Questionnaire.

Slok AH, Bemelmans TC, Kotz D, van der Molen T, Kerstjens HA, In 't Veen JC, Chavannes NH, Asijee GM, Rutten-van Mölken MP, van Schayck OC.

COPD. 2016 Aug;13(4):431-8. doi: 10.3109/15412555.2015.1118025. Epub 2016 Jan 20.

PMID:
26788838
46.

Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.

Boland MR, van Boven JF, Kruis AL, Chavannes NH, van der Molen T, Goossens LM, Rutten-van Mölken MP.

Respir Med. 2016 Jan;110:34-45. doi: 10.1016/j.rmed.2015.11.008. Epub 2015 Nov 23.

47.

Epinephrine auto-injector prescriptions to food-allergic patients in primary care in The Netherlands.

Saleh-Langenberg J, Dubois AE, Groenhof F, Kocks JW, van der Molen T, Flokstra-de Blok BM.

Allergy Asthma Clin Immunol. 2015 Oct 15;11:28. doi: 10.1186/s13223-015-0094-9. eCollection 2015.

48.

Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol.

van Boven JF, Román-Rodríguez M, Kocks JW, Soriano JB, Postma MJ, van der Molen T.

NPJ Prim Care Respir Med. 2015 Aug 6;25:15051. doi: 10.1038/npjpcrm.2015.51. No abstract available.

49.

The State of Ambient Air Quality in Two Ugandan Cities: A Pilot Cross-Sectional Spatial Assessment.

Kirenga BJ, Meng Q, van Gemert F, Aanyu-Tukamuhebwa H, Chavannes N, Katamba A, Obai G, van der Molen T, Schwander S, Mohsenin V.

Int J Environ Res Public Health. 2015 Jul 15;12(7):8075-91. doi: 10.3390/ijerph120708075.

50.

Towards tailored and targeted adherence assessment to optimise asthma management.

van Boven JF, Trappenburg JC, van der Molen T, Chavannes NH.

NPJ Prim Care Respir Med. 2015 Jul 16;25:15046. doi: 10.1038/npjpcrm.2015.46.

Supplemental Content

Loading ...
Support Center